Cooley Advises Portola Pharmaceuticals on its $140 Million IPO

Cooley LLP announced today that it advised Portola Pharmaceuticals on its $140 million initial public offering. Portola is a biopharmaceutical company focused on the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who currently have limited or no approved treatment options. It now trades on the NASDAQ Global Stock Market under the symbol “PTLA.”

More >>

Tags:  Cooley LLP | Silicon Valley

Former FERC Division of Investigations Branch Chief Daniel A. Mullen Joins Fried Frank

Fried, Frank, Harris, Shriver & Jacobson LLP announced today that Daniel A. Mullen has joined the Firm as a partner in the Litigation Department and Energy Group, resident in the Washington, DC office. Mr. Mullen will head up the Firm’s Energy Enforcement Practice and provide counsel on energy and commodities enforcement matters as well as government investigations, enforcement proceedings and litigation.

More >>

Tags:  Fried, Frank, Harris, Shriver & Jacobson LLP

Simpson Thacher Represents Blackstone Mortgage Trust in $660 Million Common Stock Offering

The Firm recently represented Blackstone Mortgage Trust, Inc. in connection with its public offering of 25,875,000 shares of class A common stock, inclusive of the shares sold pursuant to the underwriters’ full exercise of their over-allotment option, at a public offering price of $25.50 per share, or $660 million in the aggregate. Immediately following the offering, Blackstone Mortgage Trust had approximately 28.8 million shares of class A common stock outstanding. Blackstone Mortgage Trust intends to use the proceeds from the offering to originate and purchase loans through its recently commenced senior mortgage lending program and for working capital and general corporate purposes.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Simpson Thacher Represents HCA Inc. in $5.1 Billion Refinancing of its Term Loans under its Senior Secured Cash Flow Credit Facility

Simpson Thacher recently represented HCA Inc. in three refinancings of its $13.55 billion/€1.0 billion senior secured cash flow credit facility, enabling HCA to obtain lower pricing on its term loans. To effect the first transaction, HCA Inc. entered into a Joinder Agreement on April 25, 2013 pursuant to which a new, $2.374 billion tranche of B-4 term loans was established to replace HCA’s tranche B-3 term loans. Subsequently, on May 3, 2013, HCA entered a second Joinder Agreement by which $2.00 billion of new tranche B-5 term loans were created to pay down HCA’s tranche B-2 term loans. Finally, on May 22, 2013, HCA entered a third Joinder Agreement, establishing $726 million of new tranche A-4 term loans to pay down its tranche A-3 term loans.

More >>

Tags:  Simpson Thacher & Bartlett LLP | New York

Simpson Thacher Represents Smithfield Foods in its Strategic Combination with Shuanghui International

The Firm is representing Smithfield Foods (NYSE: SFD) in connection with its definitive merger agreement with Shuanghui International Holdings Limited. Under the terms of the deal, Smithfield shareholders will receive US$34.00 per share in cash, which values Smithfield at US$7.1 billion, including the assumption of Smithfield’s net debt. The transaction, which is expected to close in the second half of 2013, is subject to shareholder approval and other customary closing conditions.

More >>

Tags:  Simpson Thacher & Bartlett LLP | Hong Kong